Pricing Log in Create free account

Bionano Genomics, Inc. (BNGO) vs GlucoTrack, Inc. (GCTK)

Bionano Genomics, Inc. and GlucoTrack, Inc. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. is the larger, with a market value of $16.1M against $840.0K — 19.2× the size. Bionano Genomics, Inc. grew revenue faster over the last twelve months: 10.0% against −60.6%. GlucoTrack, Inc. has the higher net margin (0.00% vs −106.6%) and the higher return on invested capital (0.00% vs −81.7%). Across the 17 metrics below, Bionano Genomics, Inc. leads on 9 and GlucoTrack, Inc. on 8.

Valuation

Metric BNGO GCTK Medical Instruments & Supplies median
P/E n/m n/m 33.75
P/S 0.48 1.17 2.52
P/B 0.46 n/m 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales 0.72 5.10 2.88
Earnings yield (241.60%) (18,853.56%) (2.67%)
Free cash flow yield (142.62%) (6,690.23%) 0.09%

Profitability

Metric BNGO GCTK Medical Instruments & Supplies median
Gross margin 47.51% 0.00% 54.29%
Operating margin (106.67%) 0.00% 1.07%
Net margin (106.58%) 0.00% (1.61%)
Free cash flow margin (67.87%) 0.00% 1.08%
Return on equity (83.56%) (620.63%) (1.32%)
Return on assets (52.04%) (272.48%) 0.00%
Return on invested capital (81.68%) 0.00% 0.00%

Growth

Metric BNGO GCTK Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% (60.61%) 8.85%
EPS growth (last fiscal year) 94.50% 99.24% 8.65%
Revenue growth, 5-year CAGR 27.37% 28.31% 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNGO GCTK Medical Instruments & Supplies median
Debt to equity 0.11 (1.11) 0.10
Current ratio 2.48 0.46 2.48
Net debt to EBITDA 1.06 0.25 0.89

Dividend

Metric BNGO GCTK Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric BNGO GCTK Medical Instruments & Supplies median
Market cap 16.13m 840.00k 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack